【美股异动 | 脑再生科技(RGC.US)跌近20% 此前2个交易日累涨近400%】智通财经APP获悉,周三,脑再生科技

智通财经
18 Jun
【美股异动 | 脑再生科技(RGC.US)跌近20% 此前2个交易日累涨近400%】智通财经APP获悉,周三,脑再生科技(RGC.US)跌近20%,此前2个交易日累涨近400%,报62.83美元。消息面上,受到资本追捧的脑再生科技,是一家早期中药生物科学公司,主营业务主要是:开发三种液态标准化中药配方,用于治疗轻度、中度和重度的ADHD(注意缺陷多动障碍)和ASD(自闭症谱系障碍)患者。2014年创立于香港铜锣湾,脑再生科技目前主要运营及资产都在香港,员工人数只有12人。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10